Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine vs Morphine for Neonatal Abstinence Syndrome
NCT03396588Phase 3Completed
- Start
- Dec 2017
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clonidine in neonatal abstinence syndrome (NAS) (2 arms). Primary endpoints: Neonatal Intensive Care Unit Network Neurobehavioral Scale Summary Scores at 1 month, Bayley Scales of Infant and Toddler Development Third Edition at 2 years and 2 more. Started Dec 2017; status: completed.
02
Drugs
clonidine
03
Conditions
neonatal abstinence syndrome (NAS)
Beyond the preview
Go deeper on NCT03396588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03396588.